Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · IEX Real-Time Price · USD
2.250
-0.130 (-5.46%)
At close: May 23, 2024, 4:00 PM
2.260
+0.010 (0.44%)
After-hours: May 23, 2024, 7:59 PM EDT

Esperion Therapeutics Market Cap

Esperion Therapeutics has a market cap or net worth of $383.44 million as of May 23, 2024. Its market cap has increased by 130.02% in one year.

Market Cap
383.44M
Enterprise Value
705.70M
1-Year Change
130.02%
Ranking
Category
Stock Price
$2.25

Market Cap Chart

Since June 26, 2013, Esperion Therapeutics's market cap has increased from $204.10M to $383.44M, an increase of 87.87%. That is a compound annual growth rate of 5.95%.

History

DateMarket Cap% Change
May 23, 2024426.30M-5.46%
May 22, 2024450.90M-1.25%
May 21, 2024456.60M-2.83%
May 20, 2024469.90M5.10%
May 17, 2024447.10M-8.89%
May 16, 2024490.70M12.60%
May 15, 2024435.80M5.52%
May 14, 2024413.00M-2.25%
May 13, 2024422.50M1.83%
May 10, 2024414.90M4.77%
May 9, 2024396.00M2.46%
May 8, 2024386.50M-13.92%
May 7, 2024449.00M14.45%
May 6, 2024392.30M1.92%
May 3, 2024384.90M0.97%
May 2, 2024381.20M0.98%
May 1, 2024377.50M3.54%
Apr 30, 2024364.60M-1.00%
Apr 29, 2024368.30M4.75%
Apr 26, 2024351.60M-4.53%
Apr 25, 2024368.30M-6.57%
Apr 24, 2024394.20M1.91%
Apr 23, 2024386.80M9.42%
Apr 22, 2024353.50M-2.05%
Apr 19, 2024360.90M4.31%
View and export this data all the way back to 2013. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Mereo BioPharma Group 426.42M
Neurogene 422.12M
Fate Therapeutics 421.18M
Biomea Fusion 416.24M
Lexicon Pharmaceuticals 411.22M
Erasca 407.39M
Contineum Therapeutics 402.09M
Health Catalyst 399.67M
Market Cap Rankings